Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Josephson

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Expert Review of Anticancer Therapy|April 13, 2007
Superficial bladder cancer: part 2. ManagementDavid Josephson, Erik Pasin, John P Stein
Dalton Transactions (Cambridge, England : 2003)|August 11, 2018
The chameleonic reactivity of dilithio bis(alkylamido)cyclodiphosph(iii)azanes with chlorophosphinesMathew E Otang, David Josephson, Todd Duppong, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 16, 2011
Role of surgery for locally advanced and metastatic renal cell carcinomaRobert Torrey, Philippe E Spiess, Sumanta K Pal, et al.
The Canadian Journal of Urology|April 20, 2012
Integrating robotic partial nephrectomy to an existing robotic surgery programBertram Yuh, Shantel Muldrew, Anita Menchaca, et al.
Prostate Cancer and Prostatic Diseases|July 8, 2023
Investigating trends in interest for benign prostatic hyperplasia surgery options using Google TrendsJames P Daniels, Devin N Patel, Gloria Cecilia Galvan, et al.
European Urology|July 6, 2023
Diagnostic Performance and Safety of Positron Emission Tomography with <sup>18</sup>F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE)Devaki Shilpa Surasi, Matthias Eiber, Tobias Maurer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2021
Diagnostic Performance of <sup>18</sup>F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter StudyMichael J Morris, Steven P Rowe, Michael A Gorin, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Expert Review of Anticancer Therapy|April 13, 2007
Superficial bladder cancer: part 2. ManagementDavid Josephson, Erik Pasin, John P Stein
Dalton Transactions (Cambridge, England : 2003)|August 11, 2018
The chameleonic reactivity of dilithio bis(alkylamido)cyclodiphosph(iii)azanes with chlorophosphinesMathew E Otang, David Josephson, Todd Duppong, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 16, 2011
Role of surgery for locally advanced and metastatic renal cell carcinomaRobert Torrey, Philippe E Spiess, Sumanta K Pal, et al.
The Canadian Journal of Urology|April 20, 2012
Integrating robotic partial nephrectomy to an existing robotic surgery programBertram Yuh, Shantel Muldrew, Anita Menchaca, et al.
Prostate Cancer and Prostatic Diseases|July 8, 2023
Investigating trends in interest for benign prostatic hyperplasia surgery options using Google TrendsJames P Daniels, Devin N Patel, Gloria Cecilia Galvan, et al.
European Urology|July 6, 2023
Diagnostic Performance and Safety of Positron Emission Tomography with <sup>18</sup>F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE)Devaki Shilpa Surasi, Matthias Eiber, Tobias Maurer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2021
Diagnostic Performance of <sup>18</sup>F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter StudyMichael J Morris, Steven P Rowe, Michael A Gorin, et al.
Pageof 1